227 related articles for article (PubMed ID: 23650199)
1. Aspirin desensitisation for Chinese patients with coronary artery disease.
Lee JK; Tsui KL; Cheung CY; Chau CH; Chan HL; Wu KL; Cheung GS; Choi MC; Chan KK; Li SK
Hong Kong Med J; 2013 Jun; 19(3):207-13. PubMed ID: 23650199
[TBL] [Abstract][Full Text] [Related]
2. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
Rossini R; Angiolillo DJ; Musumeci G; Scuri P; Invernizzi P; Bass TA; Mihalcsik L; Gavazzi A
Am J Cardiol; 2008 Mar; 101(6):786-9. PubMed ID: 18328841
[TBL] [Abstract][Full Text] [Related]
3. Aspirin Desensitization in Patients With Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease).
Rossini R; Iorio A; Pozzi R; Bianco M; Musumeci G; Leonardi S; Lettieri C; Bossi I; Colombo P; Rigattieri S; Dossena C; Anzuini A; Capodanno D; Senni M; Angiolillo DJ
Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193678
[TBL] [Abstract][Full Text] [Related]
4. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.
Feres F; Costa RA; Abizaid A; Leon MB; Marin-Neto JA; Botelho RV; King SB; Negoita M; Liu M; de Paula JE; Mangione JA; Meireles GX; Castello HJ; Nicolela EL; Perin MA; Devito FS; Labrunie A; Salvadori D; Gusmão M; Staico R; Costa JR; de Castro JP; Abizaid AS; Bhatt DL;
JAMA; 2013 Dec; 310(23):2510-22. PubMed ID: 24177257
[TBL] [Abstract][Full Text] [Related]
5. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting.
Silberman S; Neukirch-Stoop C; Steg PG
Am J Cardiol; 2005 Feb; 95(4):509-10. PubMed ID: 15695141
[TBL] [Abstract][Full Text] [Related]
6. [Acetylsalicylic acid hypersensitivity in a patient with coronary artery disease and insulin-dependent diabetes mellitus].
Podolecka E; Ciszewski A; Kepka C; Mazurkiewicz Ł; Ruzyłło W
Kardiol Pol; 2008 Jan; 66(1):70-2. PubMed ID: 18266189
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
[TBL] [Abstract][Full Text] [Related]
8. Rapid Aspirin Desensitization is Safe and Feasible in Patients With Stable and Unstable Coronary Artery Disease: A Single-Center Experience.
Jackson M; Callaghan S; Stapleton J; Bolton S; Austin D; Muir DF; Sutton AGC; Wright RA; Williams PD; Hall JA; Carter J; de Belder MA; Swanson N
J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):359-364. PubMed ID: 30614246
[TBL] [Abstract][Full Text] [Related]
9. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel desensitization: case report and review of published protocols.
Owen P; Garner J; Hergott L; Page RL
Pharmacotherapy; 2008 Feb; 28(2):259-70. PubMed ID: 18225971
[TBL] [Abstract][Full Text] [Related]
11. Successful clopidogrel desensitization after drug-eluting stent implantation.
Kammer RT
J Invasive Cardiol; 2009 Mar; 21(3):134-5. PubMed ID: 19258645
[TBL] [Abstract][Full Text] [Related]
12. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
[TBL] [Abstract][Full Text] [Related]
13. Dual antiplatelet therapy in patients with a long coronary artery lesion over 30 mm: Determinants and impact on prognosis.
Manchuelle A; Delhaye C; Schurtz G; Sudre A; Hurt C; Bonello L; Puymirat E; Bauters C; Lemesle G
Arch Cardiovasc Dis; 2015 Apr; 108(4):235-43. PubMed ID: 25682548
[TBL] [Abstract][Full Text] [Related]
14. Clopidogrel hypersensitivity: a novel multi-day outpatient oral desensitization regimen.
Fajt M; Petrov A
Ann Pharmacother; 2010 Jan; 44(1):11-8. PubMed ID: 20009004
[TBL] [Abstract][Full Text] [Related]
15. Temporal variability in the antiplatelet effects of clopidogrel and aspirin after elective drug-eluting stent implantation. An ADAPT-DES substudy.
Nührenberg TG; Stratz C; Leggewie S; Hochholzer W; Valina CM; Gick M; Kirtane AJ; Stone GW; Neumann FJ; Trenk D
Thromb Haemost; 2015 Nov; 114(5):1020-7. PubMed ID: 26305340
[TBL] [Abstract][Full Text] [Related]
16. Rapid oral aspirin desensitization for patients with aspirin allergy requiring dual antiplatelet therapy.
Hobbs L; Lyle B
Conn Med; 2008 Feb; 72(2):87-9. PubMed ID: 18306836
[No Abstract] [Full Text] [Related]
17. Aspirin sensitivity and coronary artery disease: implications for the practicing cardiologist.
Pattanaik D; Lieberman P; Das P
Future Cardiol; 2012 Jul; 8(4):555-62. PubMed ID: 22871195
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.
Baber U; Akhter M; Kothari S; Sharma SK; Kini A
J Invasive Cardiol; 2010 Feb; 22(2):80-3. PubMed ID: 20124594
[TBL] [Abstract][Full Text] [Related]
19. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial.
Lee CW; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Han S; Lee SG; Seong IW; Rha SW; Jeong MH; Lim DS; Yoon JH; Hur SH; Choi YS; Yang JY; Lee NH; Kim HS; Lee BK; Kim KS; Lee SU; Chae JK; Cheong SS; Suh IW; Park HS; Nah DY; Jeon DS; Seung KB; Lee K; Jang JS; Park SJ
Circulation; 2014 Jan; 129(3):304-12. PubMed ID: 24097439
[TBL] [Abstract][Full Text] [Related]
20. Hypertension as a risk factor for aspirin and clopidogrel resistance in patients with stable coronary artery disease.
Akturk IF; Caglar FN; Erturk M; Tuncer N; Yalcın AA; Surgit O; Uzun F; Caglar IM
Clin Appl Thromb Hemost; 2014 Oct; 20(7):749-54. PubMed ID: 23493759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
